This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Eurogentec S.a., Université De Mons, Université Libre De Bruxelles. Active years: 2015.
Company Filing History:
1 out of 5 
1 out of 12 
1 out of 99 
Years Active: 2015
Title: Corine Sermeus: Innovator in Synthetic Peptide Molecules
Introduction: Corine Sermeus, an accomplished inventor from Silly, Belgium, has made significant contributions to the field of biotechnology through her innovative research. With a firm focus on pancreatic beta cell biomarkers, she has developed a patent that showcases her expertise and dedication to science.
Latest Patents: Corine holds one patent titled "Molecules specifically binding pancreatic beta cells biomarkers." This groundbreaking invention provides a synthetic peptide molecule composed of 25 amino acids that specifically binds to an FXYD2-gamma isoform of pancreatic beta cells. This advancement holds promise for improving the understanding and treatment of diabetes.
Career Highlights: Throughout her career, Corine has worked with notable institutions including Université de Mons and Université Libre de Bruxelles. Her academic and research endeavors have greatly contributed to her reputation as a leading figure in her field.
Collaborations: Corine has collaborated with esteemed colleagues such as Robert Muller and Decio L. Eizirik, whose expertise and insights have further enriched her work in the research of pancreatic biomarkers.
Conclusion: Corine Sermeus is a remarkable inventor whose contributions to synthetic peptide research have the potential to pave the way for new therapeutic strategies in the treatment of diabetes. Her innovative spirit and collaborative efforts with leading researchers continue to inspire advancements in the field of biotechnology.